19 /100
LOW RISK
Score updated May 29, 2026

BMGL — Basel Medical Group Ltd Dilution Risk Tracker

Track BMGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BMGL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
62
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.63 below $1 exchange minimum
🔔 Track BMGL — Get forecast alerts →

💹 Market Data

Market Cap$10.99M
Shares Outstanding18.79M
Float6.02M
Cash$7.68M
Debt$5.11M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 50.0% shares (2025Q4 vs prior)
11 institutional holders · 144.8K shares
#1 Ground Swell Capital, LLC 33.7K shares
#2 XTX Topco Ltd 30.4K shares
#3 CITADEL ADVISORS LLC 24.7K shares
+ 8 more holders Sign up free to view →

📉 Short Interest

Short Interest110.0K
Days to Cover5.4
% of Float1.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track BMGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BMGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BMGL
📊 BMGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BMGL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.